Compare iShares MSCI United Kingdom (FTSE) (EWU) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI United Kingdom (FTSE) vs Tempus AI — how do they compare? iShares MSCI United Kingdom (FTSE) trades at $47.15 (market cap $3.66B), while Tempus AI trades at $70.29 (market cap $12.58B). The key difference: Tempus AI is far larger — about 3.4× iShares MSCI United Kingdom (FTSE)'s market cap, and iShares MSCI United Kingdom (FTSE) is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI United Kingdom (FTSE) for 46 Days and Tempus AI for 22 Days on average.
| EWU | TEM | |
|---|---|---|
Market Cap | $3.66B | $12.58B |
Volume | 573,447 | 7,444,569 |
Sector | Broad Market / Factor | Broad Market / Factor |
52-Week High | $49.39 | $99.28 |
52-Week Low | $41.34 | $41.55 |
Typical Hold Time | 46 Days | 22 Days |
Enterprise Value | — | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWU, the iShares MSCI United Kingdom ETF, trades at $45.93, down 0.95% amid broader UK market pressures. Technical indicators show a bearish trend with moving averages signaling sell pressure, though RSI levels suggest potential oversold conditions. The fund faces headwinds from rising UK gilt yields and inflation concerns, while recent government support for housebuilders provides some sector-specific optimism. Financial ratios are not applicable as this is an ETF tracking UK equities.
The outlook remains cautious given macroeconomic pressures on UK markets, though oversold technical conditions may present near-term opportunities. Key risks include persistent inflation, rising interest rates, and political uncertainty surrounding the upcoming budget. Investors should monitor UK economic data and central bank policy decisions for directional cues.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares MSCI United Kingdom (FTSE)
EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.
Read more on EWU →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
